The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...

STORY: Shares of Pfizer rose as much as four percent in Monday morning trading after activist investor Starboard Value took ...

Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine.

AbbVie’s immunology duo Skyrizi and Rinvoq is, in a rare blip this year, not leading the pharma DTC monthly rankings as ...

As of now, Pfizer’s stock has recorded a year-to-date (YTD) performance of +3.73%. In contrast, the S&P 500 has experienced a much more robust gain of +20.57%. This stark difference in performance ...

Pharmaceutical giant Pfizer ($PFE) is facing pressure from activist investor Starboard Value, which recently disclosed a $1 ...

In September, Quebec launched an RSV vaccination campaign for Quebecers who are at least 60 years old and living in long-term ...

The CDC is attempting to get the COVID-19 shot into more arms by asking physicians and pharmacists to recommend the updated ...

Activist investor Starboard Value has acquired a significant stake in Pfizer, valued at around $1 billion, as it aims to ...